POLUZZI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 7.992
EU - Europa 6.828
AS - Asia 2.210
AF - Africa 451
SA - Sud America 39
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.540
Nazione #
US - Stati Uniti d'America 7.961
GB - Regno Unito 1.887
IT - Italia 1.560
DE - Germania 886
SE - Svezia 820
VN - Vietnam 819
CN - Cina 738
IN - India 386
UA - Ucraina 342
IE - Irlanda 298
FR - Francia 268
RU - Federazione Russa 215
TG - Togo 213
ZA - Sudafrica 127
EE - Estonia 107
JO - Giordania 71
BG - Bulgaria 59
BE - Belgio 57
FI - Finlandia 56
CH - Svizzera 55
CI - Costa d'Avorio 52
NG - Nigeria 31
SG - Singapore 31
AT - Austria 30
NL - Olanda 30
CA - Canada 29
JP - Giappone 29
HR - Croazia 28
HK - Hong Kong 26
PL - Polonia 24
PT - Portogallo 24
ES - Italia 22
TR - Turchia 20
SC - Seychelles 18
TW - Taiwan 16
GR - Grecia 15
AU - Australia 14
BR - Brasile 13
RO - Romania 12
IR - Iran 10
UZ - Uzbekistan 9
CZ - Repubblica Ceca 8
DK - Danimarca 8
ID - Indonesia 8
CO - Colombia 7
IL - Israele 7
CL - Cile 6
PE - Perù 6
KR - Corea 5
LB - Libano 5
PH - Filippine 5
SA - Arabia Saudita 5
SM - San Marino 5
TH - Thailandia 5
AR - Argentina 4
EG - Egitto 4
SY - Repubblica araba siriana 4
DZ - Algeria 3
MT - Malta 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CY - Cipro 2
MY - Malesia 2
NO - Norvegia 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
BA - Bosnia-Erzegovina 1
EU - Europa 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
MU - Mauritius 1
MX - Messico 1
PA - Panama 1
SI - Slovenia 1
UG - Uganda 1
VE - Venezuela 1
Totale 17.540
Città #
Southend 1.694
Fairfield 914
Chandler 901
Ashburn 775
Dong Ket 595
Wilmington 457
Princeton 417
Woodbridge 407
Seattle 376
Houston 368
Ann Arbor 362
Bologna 337
Cambridge 296
Dublin 290
Lomé 213
Jacksonville 204
Westminster 146
Nanjing 135
Padova 121
Redmond 114
Berlin 112
Saint Petersburg 84
Bremen 79
Shenyang 79
Milan 77
Medford 75
Rome 75
Amman 71
Beijing 68
New York 67
San Diego 65
Turin 63
Jinan 61
Mülheim 57
Sofia 56
Brussels 53
Helsinki 53
Abidjan 52
Falls Church 47
Florence 47
Hebei 47
Nanchang 46
London 41
Bern 39
Dearborn 38
Biella 34
Jiaxing 32
Redwood City 31
Abeokuta 30
Des Moines 30
Olalla 30
Changsha 27
San Venanzo 27
Tianjin 27
Zhengzhou 24
Boardman 23
Paris 22
Vienna 22
Porto 20
Haikou 18
Norwalk 18
Bühl 17
Hangzhou 17
Los Angeles 17
Messina 17
Tokyo 17
Mahé 16
Singapore 16
Cesena 15
San Francisco 15
Boydton 14
Chicago 14
Frankfurt am Main 14
Miami 14
Ningbo 14
Taipei 14
Toronto 14
Central 13
Guangzhou 12
Istanbul 12
Lanzhou 12
Kunming 11
Napoli 11
Pune 11
Torino 11
Warsaw 11
Fuzhou 10
Palermo 10
Phoenix 10
Rheinfelden 10
Ferrero 8
Frankfurt Am Main 8
Groningen 8
Monselice 8
Reggio Emilia 8
Taizhou 8
Washington 8
Amsterdam 7
Bari 7
Modena 7
Totale 11.555
Nome #
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. 426
ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance 370
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 346
Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project 251
ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance 221
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 211
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 198
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 189
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 171
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 171
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 170
Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study 159
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 158
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 155
A 3 year survey on the use of antibacterial agents in five Italian hospitals. 153
Antibacterial macrolides: a drug class with a complex pharmacological profile 151
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 145
Farmacoutilizzazione in ospedale: analisi delle variabilità in una realtà regionale 145
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 145
Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System 144
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. 144
An update on the first decade of the European centralized procedure: how many innovative drugs? 138
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 138
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 137
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health 134
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 130
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting 129
An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. 126
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 125
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database. 124
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 123
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 121
Association between Paraesthesia and Local Anesthetics: Data Mining of the Public Version of the FDA Adverse Event Reporting System, 121
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 119
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit 117
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis 117
Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics 116
A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. 116
Social and clinical descriptors of antipsychotic prescription 116
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 115
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development 115
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 114
Drug-induced Kounis syndrome: A matter of pharmacovigilance 111
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 110
Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection 109
Association between the use of proton pump inhibitors and cardiovascular events: A note of caution 109
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project 108
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 108
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics 107
Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database 106
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe 105
Antibiotic use in Italian hospitals 2002-2004. 104
Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System 104
Pattern of NSAID use in the Italian general population: a questionnaire-based survey. 104
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 104
Initial treatment of hypertension and adherence to therapy in general practice in Italy 104
Excipients in medicinal products used in gastroenterology as a possible cause of side effects. 102
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 100
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis 100
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 99
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy 98
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 98
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements 98
Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy 97
Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. 97
The hERG K+ channel: target and antitarget strategies in drug development. 97
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. 97
Developing a Method To Identify Prescribing Profiles of Antihypertensive Drugs in General Practice. 96
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective 96
null 95
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 95
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE? 95
Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions 95
Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara. 93
Diabetes is associated with decreased migraine risk: A nationwide cohort study 93
Apparato Gastroenterico 92
Predictors of non-adherence with oral bisphosphonates: an Italian retrospective cohort study on administrative databases 92
Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. 91
Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period. 90
Use of azithromycin and risk of ventricular arrhythmia 89
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region 88
Macrolides and Torsadogenic Risk: Emerging Issues from the FDA Pharmacovigilance Database 88
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 88
Stroke, Migraine and Triptans: From Bedside to Bench 88
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database 87
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. 86
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System. 86
The adherence to antihypertensive treatments: an Italian survey by using prescription databases. 85
Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS). 85
Comment on: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus” 85
Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease 84
null 84
Farmaci lassativi e purganti 83
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden. 83
Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. 82
Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders 82
Risk-management of natalizumab: a drug utilization study on duration of therapy and cause of discontinuation in Emilia-Romagna region 82
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 82
Aderenza alla terapia antidepressiva in Emilia-Romagna 81
Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence 80
Totale 12.291
Categoria #
all - tutte 44.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 171
Totale 44.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019409 0 0 0 0 0 0 0 0 0 163 56 190
2019/20203.837 591 131 82 287 343 346 443 480 519 268 125 222
2020/20212.665 467 163 43 132 60 151 66 175 218 150 167 873
2021/20223.831 401 121 201 192 318 226 160 267 169 229 919 628
2022/20234.598 505 599 350 549 276 322 171 304 725 189 385 223
2023/20241.775 123 226 227 297 161 209 88 344 46 54 0 0
Totale 18.145